Andrew M. Weiss Joins Sofinnova Partners as a Venture Partner

Sofinnova Partners has appointed experienced medical device executive Andrew M. Weiss as a venture partner.  
 
Based in San Francisco, Weiss is in charge of investigating global medical device investment opportunities across Sofinnova Partners’ strategic platform. He is currently an independent board member at May Health and SafeHeal, two Sofinnova portfolio companies. Weiss’ ties to Sofinnova date back 20 years. 

“It’s fantastic to have Andy back working with Sofinnova Partners. He is an outstanding leader with impeccable credentials in the medical devices sector,” Sofinnova Partners Chairman/Managing Partner Antoine Papiernik said. “His performance at ReCor is legendary.”
 
In 2013, Weiss was brought in as CEO to lead ReCor Medical, a company founded in 2009 by Mano Iyer, then an entrepreneur in residence at Sofinnova and now a partner in the Sofinnova medtech acceleration team. Weiss led ReCor, a pioneer in the use of ultrasound renal denervation to treat hypertension, as it scaled up to 175 employees, conducted clinical trials, and was purchased by Otsuka Medical Devices in 2018. He also supervised preparations for ReCor’s U.S. Food and Drug Administration pre-market approval, achieved in November 2023. Sofinnova Partners was the sole VC investor in ReCor at the time of the sale. Weiss retired from ReCor/Otsuka Medical Devices in April 2023.
 
Prior to ReCor, Weiss held leadership roles including president and CEO of Vital Images (acquired by Toshiba), vice president and general manager of Medtronic’s Surgical Navigation Systems and Neurological Businesses, and president and CEO of CoAxia, which was sold to Zoll Medical.
 
Weiss graduated from the Massachusetts Institute of Technology with a degree in mechanical engineering and earned an MBA from the Columbia University Graduate School of Business.

“I share Sofinnova’s passion for finding, nurturing and bringing new medical device therapies to patients,” Weiss stated. “Having worked both informally and as a portfolio company CEO with Sofinnova for the past 20 years, I know they have the best team, and is the gold-standard medical device venture group on a global basis. I am honored to become part of this team.”
 
Sofinnova Partners is a European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London, and Milan, the firm brings together professionals worldwide with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact the future.